Activin and Inhibin

ALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC 50 of 9 nM, and over 700-fold selectivity against ALK3Form:SolidIC50&amp: Target:ACVR1 9 nM (IC 50 ).

ALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC 50 of 9 nM, and over 700-fold selectivity against ALK3Form:SolidIC50&amp: Target:ACVR1 9 nM (IC 50 ).

ALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC 50 of 9 nM, and over 700-fold selectivity against ALK3Form:SolidIC50&amp: Target:ACVR1 9 nM (IC 50 ).

ALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC 50 of 9 nM, and over 700-fold selectivity against ALK3Form:SolidIC50&amp: Target:ACVR1 9 nM (IC 50 ).

ALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC 50 of 9 nM, and over 700-fold selectivity against ALK3IC50&amp: Target:ACVR1 9 nM (IC 50 ).

ALK2-IN-4 is a potent ALK2 inhibitor extracted from patent WO2020086963A1, compound Formula I free baseForm:SolidIC50&amp: Target:ACVR1.

ALK2-IN-4 is a potent ALK2 inhibitor extracted from patent WO2020086963A1, compound Formula I free baseForm:SolidIC50&amp: Target:ACVR1.

ALK2-IN-4 is a potent ALK2 inhibitor extracted from patent WO2020086963A1, compound Formula I free baseForm:SolidIC50&amp: Target:ACVR1.

ALK2-IN-4 is a potent ALK2 inhibitor extracted from patent WO2020086963A1, compound Formula I free baseForm:SolidIC50&amp: Target:ACVR1.

ALK2-IN-4 is a potent ALK2 inhibitor extracted from patent WO2020086963A1, compound Formula I free baseForm:SolidIC50&amp: Target:ACVR1.

ALK2-IN-4 is a potent ALK2 inhibitor extracted from patent WO2020086963A1, compound Formula I free baseIC50&amp: Target:ACVR1.

ALK2-IN-4 succinate is a potent ALK2 inhibitor extracted from patent WO2020086963A1, compound Formula I free baseForm:SolidIC50&amp: Target:ACVR1.